Connealy Pamela Ann
Orchestra BioMed Holdings, Inc. · Director
Connealy Pamela Ann is listed in filings as Director at Orchestra BioMed Holdings, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2026, including purchase activity. Recent filings connect the profile to Orchestra BioMed Holdings, Inc. (OBIO) and Pyxis Oncology, Inc. (PYXS). The current snapshot covers public activity from Jun 21, 2024 to Jun 25, 2026. Reported amounts are shown as $86.0K to $163.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $11k5.5k shares | BuyNov 26, 2024 | $2.00 | $2.36 | |
| $163k83.4k shares | BuyNov 26, 2024 | $1.96 | $2.36 |